Metabolic and endocrine disorders encompass a broad spectrum of conditions with significant health implications.Effective pharmacotherapy plays a pivotal role in the management of these disorders, aiming to alleviate symptoms, improve quality of life, and mitigate long-term complications.This review provides a comprehensive overview of current pharmacotherapy strategies for various metabolic and endocrine disorders, including diabetes mellitus, obesity, dyslipidemia, thyroid disorders, adrenal disorders, pituitary disorders, and gonadal disorders.Key oral and injectable medications, their mechanisms of action, and clinical efficacy are discussed.Additionally, challenges such as medication adherence, side effects, individualized treatment approaches, and emerging therapies are addressed.Through this review, we aim to provide clinicians with valuable insights into evidence-based pharmacotherapy strategies to optimize patient outcomes in the management of metabolic and endocrine disorders.1.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: